Akebia Therapeutics, Inc.AKBANASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-77.46
↓ 611% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineCompressed
Average
-10.89
Historical baseline
PeriodValueYoY Change
2025-77.46-1241.4%
2024-5.77-29.0%
2023-4.48-300.0%
2022-1.12+15.8%
2021-1.33-32.0%
2020-1.01+62.3%
2019-2.68+28.8%
2018-3.76+55.3%
2017-8.41-190.8%
2016-2.89-